Kate Excoffon, PhD

Wright State University, Associate Professor

What is your current professional status?

Associate Professor of Biological Sciences

What is your work setting (i.e. academic institution, government organization (i.e. FDA, NIH, etc.), bio-industry/pharmaceutical company, etc.)

Wright State University

What is your scientific area of research?

Adenovirus and AAV virology and cell biology

Why do you want to be a mentor?

The mentoring I have received has been pivotal to my advancement and success. Key advice at just the right time can have an important impact on career trajectory.

As a mentor, what are you hoping to gain from this experience?

To be inspired by inspiring others.

How important are the following in the selection of a mentee: (1 – 5 scale, 1 = most important, 5 = least important)

  • Compatibility of Scientific Specialties: 1 (most)
  • Geographic Location: 5 (least)
  • Professional Status / Success: 4
  • Compatibility of Career Path: 3
  • Communication Style: 2

Summarize in a brief paragraph (150 words or less), please provide a biography that describes who you are and what you do in the field of gene and/or cell therapy:

I am a scientist, educator, mother, and wife. I am primarily driven by curiosity. Everything always becomes an experiment. During my PhD I discovered that an alternative form of lipoprotein lipase was so efficiently expressed that it could even make AAV look good. The result: Glybera. During my post doc I tried to make an AAV that could efficiently infect human airway. The product? A novel AAV (AAV2.5T) that will hopefully enter clinical trials soon.

During my post doc I also tried to improve our understanding of the adenovirus receptor, CAR. Now as a University faculty member I have discovered molecules that can up and downregulate CAR and adenovirus infection. At the same time I balance classes as large as 170 students and have a relatively happy household. The secret is my fantastic group of mentors who help me keep life in perspective.

View CV

22nd Annual Meeting
April 29 – May 2 | Washington D.C.